No topoisomerase I alteration in a neuroblastoma model with in vivo acquired resistance to irinotecan

Eitemau Tebyg

• Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts.
  gan: Vassal, G., et al.
  Cyhoeddwyd: (1996)
• Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts
  gan: Geoerger, B, et al.
  Cyhoeddwyd: (2003)
• Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations
  gan: Boland, I, et al.
  Cyhoeddwyd: (1999)
• In Vivo Elimination of Acentric Double Minutes Containing Amplified MYCN from Neuroblastoma Tumor Cells Through the Formation of Micronuclei
  gan: Valent, Alexander, et al.
  Cyhoeddwyd: (2001)
• Activity of irinotecan and temozolomide in the presence of O(6)-methylguanine-DNA methyltransferase inhibition in neuroblastoma pre-clinical models
  gan: Cai, W, et al.
  Cyhoeddwyd: (2010)